Cutting edge research deserves high-tech solutions
Reno-NL: your partner in (pre)clinical innovation
Reno-NL, a spin-off from the University Medical Center Groningen (The Netherlands), was founded in 2025 and built on decades of experience in organ machine perfusion and preservation technology research.
Our multidisciplinary team of highly skilled and passionate professionals has played a pioneering role in the development of this transformative technology.
We specialize in extracorporeal kidney perfusion and downstream analysis, driving medical innovation with high translational accuracy. Beyond transplantation, our experimental platforms are ideally suited for drug testing and medical device research, enabling pharmaceutical and health-tech companies to develop next-generation solutions.
With a tailored, research-driven approach, we deliver clinically relevant, high-quality results that make the transition to patient applications more predictable, cost-effective, and impactful.
Fields of interest
Transplantation
Pharmacology
Medical device
Prof. Dr. Henri Leuvenink: Main founder
"We are a multidisciplinary team of professionals specialized in organ perfusion. By combining deep scientific expertise with advanced technology, we help partners to accelarate medical innovations."
Why choose for Reno-NL?
At Reno-NL, we offer specialized contract research services in organ perfusion, built on a collaborative, client-centered approach. From initial research questions to final outcomes, we co-create tailored strategies that align with your goals ensuring relevance, reliability, and clinical impact. Our team works closely with you throughout the process, adapting as needed to deliver high-quality, actionable results. By combining your vision with our scientific expertise, we transform complex challenges into innovative solutions.
By using human-relevant perfusion models, we eliminate the need for less predictive in vitro systems and costly in vivo animal studies saving time, reducing expenses, and improving translational accuracy. This approach not only lowers the risk of failure in later clinical phases but also enhances the overall cost-effectiveness of your R&D efforts. Together, we turn complex questions into actionable solutions that accelerate progress and bring medical innovations closer to the patient.
Some of our existing collaborators
